IBRX
ImmunityBio (IBRX) Stock Forecast
Review ImmunityBio (IBRX) forecast with server-rendered company data, supporting context and links to related investor research.
- Short-term score
- 52
- Long-term score
- 47
- Overall BTI score
- 47
- Overall outlook
- High Risk
ImmunityBio (IBRX) Stock Forecast research
The IBRX forecast page separates the available short-term and long-term BTI outlooks. These scenarios summarize processed market and company data; they are not a promise of price performance or a substitute for current company guidance.
Use the forecast with the earnings, financials and valuation pages. Changes in results, interest rates, competition or market expectations can quickly make an earlier outlook less relevant.